Dada T, Ramesh P, Sethi A, et al. Ethics of glaucoma widgets. J Curr Glaucoma Pract 2020;14(3):77–80. DOI: 10.5005/jp-journals-10078-1288
Jabłońska J, Lewczuk K, Konopińska J, et al. Microinvasive glaucoma surgery: a review and classification of implant-dependent procedures and techniques. Acta Ophthalmol 2022;100(2):e327–e338. DOI: 10.1111/aos.14906
Böke H. [History of cyclodialysis. In memory of Leopold Heine 1870-1940]. Klin Monbl Augenheilkd 1990;197(4):340–348. DOI: 10.1055/s-2008-1046291 2280572
Dada T, Sharma R, Sinha G, et al. Cyclodialysis-enhanced trabeculectomy with triple Ologen implantation. Eur J Ophthalmol 2016;26(1):95–97. DOI: 10.5301/ejo.5000633
Gills JP. Cyclodialysis implants in human eyes. Am J Ophthalmol 1966;61(5 Pt 1):841–846. DOI: 10.1016/0002-9394(66)90922-6
Dada T, Shakrawal J, Ramesh P, et al. Trabeculectomy augmented with limited deep sclerectomy and cyclodialysis with use of scleral tissue as a spacer. J Ophthalmic Vis Res 2022;17(4):596–600. DOI: 10.18502/jovr.v17i4.12342
Melamed S, Ben Simon GJ, Goldenfeld M, et al. Efficacy and safety of gold micro shunt implantation to the supraciliary space in patients with glaucoma: a pilot study. Arch Ophthalmol. 2009;127(3):264–269. DOI: 10.1001/archophthalmol.2008.61
Skaat A, Sagiv O, Kinori M, et al. Gold micro-shunt implants versus Ahmed glaucoma valve: long-term outcomes of a prospective randomized clinical trial. J Glaucoma 2016;25(2):155–161. DOI: 10.1097/IJG.0000000000000175
Hueber A, Roters S, Jordan JF, et al. Retrospective analysis of the success and safety of gold micro shunt implantation in glaucoma. BMC Ophthalmol 2013;13:35. DOI: 10.1186/1471-2415-13-35
Figus M, Posarelli C, Passani A, et al. The supraciliary space as a suitable pathway for glaucoma surgery: ho-hum or home run? Surv Ophthalmol 2017;62(6):828–837. DOI: 10.1016/j.survophthal.2017.05.002
Rękas M, Pawlik B, Grala B, et al. Clinical and morphological evaluation of gold micro shunt after unsuccessful surgical treatment of patients with primary open-angle glaucoma. Eye (Lond) 2013;27(10):1214–1217. DOI: 10.1038/eye.2013.154
Fili S, Janoud L, Vastardis I, et al. The STARflo™ glaucoma implant: a single-centre experience at 24 months. Graefes Arch Clin Exp Ophthalmol 2019;257(12):2699–2706. DOI: 10.1007/s00417-019-04461-5
Vold S, Ahmed II, Craven ER, et al. Two-year COMPASS Trial results: supraciliary microstenting with phacoemulsification in patients with open-angle glaucoma and cataracts. Ophthalmology 2016;123(10):2103–2112. DOI: 10.1016/j.ophtha.2016.06.032
Höh H, Grisanti S, Grisanti S, et al. Two-year clinical experience with the CyPass micro-stent: safety and surgical outcomes of a novel supraciliary micro-stent. Klin Monbl Augenheilkd 2014;231(4):377–381. DOI: 10.1055/s-0034-1368214
García-Feijoo J, Rau M, Grisanti S, et al. Supraciliary micro-stent implantation for open-angle glaucoma failing topical therapy: 1-year results of a multicenter study. Am J Ophthalmol 2015;159(6): 1075–1081.e1. DOI: 10.1016/j.ajo.2015.02.018
Kerr NM, Wang J, Perucho L, et al. The safety and efficacy of supraciliary stenting following failed glaucoma surgery. Am J Ophthalmol 2018;190:191–196. DOI: 10.1016/j.ajo.2018.03.043
Law SK, Salazar D, Yu F, et al. Efficacy of combined suprachoroidal stent and cataract surgery in patients with glaucoma. J Glaucoma 2020;29(8):627–638. DOI: 10.1097/IJG.0000000000001554
Bhartiya S, Shaarawy T. The quest for the holy grail of glaucoma surgery: does cypass herald the end? J Curr Glaucoma Pract 2018;12(3):99–101. DOI: 10.5005/jp-journals-10028-1252
Myers JS, Masood I, Hornbeak DM, et al. Prospective evaluation of two iStent(®) trabecular stents, one Istent Supra(®) suprachoroidal stent, and postoperative prostaglandin in refractory glaucoma: 4-year outcomes. Adv Ther 2018;35(3):395–407. DOI: 10.1007/s12325-018-0666-4
Denis P, Hirneiß C, Reddy KP, et al. A first-in-human study of the efficacy and safety of miniject in patients with medically uncontrolled open-angle glaucoma (STAR-I). Ophthalmol Glaucoma 2019;2(5): 290–297. DOI: 10.1016/j.ogla.2019.06.001
Denis P, Hirneiß C, Durr GM, et al. Two-year outcomes of the MINIject drainage system for uncontrolled glaucoma from the STAR-I first-in-human trial. Br J Ophthalmol 2022;106(1):65–70. DOI: 10.1136/bjophthalmol-2020-316888
García Feijoó J, Denis P, Hirneiß C, et al. A European study of the performance and safety of MINIject in patients with medically uncontrolled open-angle (STAR-II)glaucoma. J Glaucoma 2020;29(10):864–871. DOI: 10.1097/IJG.0000000000001632